Vivani Medical
VANI
31 hedge funds and large institutions have $3.53M invested in Vivani Medical in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0.21% less ownership
Funds ownership: 6.99% → 6.78% (-0.21%)
3% less capital invested
Capital invested by funds: $3.62M → $3.53M (-$95.1K)
3% less funds holding
Funds holding: 32 → 31 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$15.6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$10.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.58K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.64K |
| 5 |
Morgan Stanley
New York
|
+$809 |
Top Sellers
| 1 |
Millennium Management
New York
|
-$95.9K |
| 2 |
PCM
Prelude Capital Management
New York
|
-$11.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$11K |
| 4 |
Jane Street
New York
|
-$5.07K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.4K |
VANI Hedge Fund Activity: Q4 2023 in Review
31 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q4 2023, worth a combined $3.53M — down 2.6% from $3.62M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VANI and 5 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $15.6K. The largest seller was Millennium Management, exiting entirely with an estimated $95.9K sold.
- 31 institutional investors held Vivani Medical (VANI) as of Q4 2023, down from 32 in Q3 2023.
- Funds reported $3.53M of Vivani Medical stock for Q4 2023, down 2.6% quarter-over-quarter.
- 5 funds opened new Vivani Medical positions in Q4 2023 and 6 closed out, a net change of -1 holder.
- The largest Vivani Medical buyer in Q4 2023 was Renaissance Technologies, an estimated $15.6K added.
- The largest Vivani Medical seller in Q4 2023 was Millennium Management, an estimated $95.9K sold.
Based on aggregated 13F filings for Q4 2023.